In addition, a pan-pancreatic cancer cell lines analysis, iRegulon analysis and immunohistochemical results of PUMCH cohorts suggested that S100A14-FOXL1-PD-L1 pathway may be a potential signal axes inhibiting CD8 + T cell activation. This evidence concerns the gene FOXL1 and pancreatic neoplasm.